BeOne Medicines AG - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US07725L1026

SecurityONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
Institution1832 Asset Management L.P.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
1832 Asset Management L.P. closes position in ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)

On February 13, 2026 - 1832 Asset Management L.P. filed a 13F-HR form disclosing ownership of 0 shares of BeOne Medicines AG - Depositary Receipt (Common Stock) (US:ONC) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 80,000 shares of BeOne Medicines AG - Depositary Receipt (Common Stock). The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 0 -100.00 0
2025-11-14 2025-09-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 80,000 80,000 27,256 0.0215
2023-05-12 2023-03-31 13F BEIGENE SPONSORED ADR 07725L102 0 -800 -100.00 0 -100.00
2023-02-15 2022-12-31 13F BEIGENE SPONSORED ADR 07725L102 800 742 1,279.31 176 2,087.50 0.0004
2022-11-14 2022-09-30 13F BEIGENE SPONSORED ADR 07725L102 58 58 8 0.0000
2022-02-15 2021-12-31 13F BEIGENE SPONSORED ADR 07725L102 0 -30,800 -100.00 0 -100.00
2021-11-15 2021-09-30 13F BEIGENE SPONSORED ADR 07725L102 30,800 -2,000 -6.10 11,207 -4.16 0.0210
2021-08-20 2021-06-30 13F/A-1 BEIGENE SPONSORED ADR 07725L102 32,800 2,500 8.25 11,693 15.36 0.0226
2021-08-16 2021-06-30 13F BEIGENE SPONSORED ADR 07725L102 32,800 2,500 11,693 0.0226
2021-05-17 2021-03-31 13F BEIGENE SPONSORED ADR 07725L102 30,300 4,000 15.21 10,136 50.65 0.0219
2021-02-16 2020-12-31 13F BEIGENE SPONSORED ADR 07725L102 26,300 26,300 6,728 0.0157
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.